Active substance:
- Rabbit haemorrhagic disease virus, type 1, capsid protein VP60a
- Rabbit haemorrhagic disease virus, type 2, capsid protein VP60ab
Route of administration:
-
Subcutaneous use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Rabbit